The effect of dietary soy supplementation on hot flushes

Obstetrics and Gynecology

Volumn 91, Issue 1, 1998, Pages 6-11

  Albertazzi, Paola ^a   Pansini, Francesco ^b   Bonaccorsi, Gloria ^b   Zanotti, Laura ^b   Forini, Elena ^b   De Aloysio, Domenico ^b  

^a MAGGIORE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHYTOESTROGEN; PLACEBO; SOYBEAN PROTEIN;

ADULT; ANALYTIC METHOD; ARTICLE; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GASTROINTESTINAL SYMPTOM; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN ISOLATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0031982756     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00597-8     Document Type: Article

References (22)

1. 1. Coldiz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogen and progestin and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332:1589-93.
2. 2. Jick H, Derby EL, Myres MW, Vasilakis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogen. Lancet 1996;348:981-3.
3. 3. Lock M. Encounters with aging: Mythologies of menopause in Japan and North America. Berkeley and Los Angeles: University of California Press, 1993.
4. 4. Notelovitz M. Estrogen replacement therapy indications, contraindications, and agent selection. Am J Obstet Gynecol 1989;161:8-17.
5. 5. Nagasawa H. Nutrition and breast cancer: A survey of experimental and epidemiological evidence. IRCS J Med Sci 1980;8:317-25.
6. 6. Kato I, Tominaga S, Kuroishi T. Relationship between westernisation of dietary habits and mortality from breast and ovarian cancer in Japan. Jpn J Cancer Res 1987;78:349-57.
7. 7. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991;83:541-6.
8. 8. Barnes S, Grubbs C, Setchell K, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. In: Pariza M, ed. Mutagens and carcinogens in the diet. New York: Wiley-Liss, 1990:239-53.
9. 9. Kupperman HS, Blatt MHG, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 1953;13:688-703.
10. 10. Murkies A, Lombard C, Strauss BJG, Wilcox G, Burgher HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes: Effect of soy and wheat. Maturitas 1995; 21:189-95.
11. 11. Walz E. Isoflavon-und Sapogenin-Glucoside in Sojahispia. Justus Liebigs Ann Chem 1931;489:118-55.
12. 12. Adlercreutz HCT, Goldin BR, Gorbach SL, Hockerstedt KAV, Watanabe S, Hamalainen EK, et al. Soybean phytoestrogen and cancer risk. J Nutr 1995;125:757S-770S.
13. 13. Whitten PL, Naftolin F. Dietary plant estrogen: A biological active background for estrogenic action. In: Hochberg R, Naftolin F, eds. The new biology of steroid hormones. New York: Raven Press, 1991:155-67.
14. 14. Haas S, Walsh B, Evans S, Krache M, Ravnikar V, Schiff I. The effect of transdermal estradiol on hormone and metabolic dynamics over a 6-week period. Obstet Gynecol 1988;71:671-6.
15. 15. Adlercreutz H. Western diet and western diseases: Some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990;50(suppl):3-23.
16. 16. Knight DC, Eden JA. A review of the clinical effects of phytoestrogen. Obstet Gynecol 1996;87:897-904.
17. 17. Cassidy A, Bingham S, Setchel KDR. Biological effects of a diet of soy protein rich isoflavons on menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40.
18. 18. Parkin DM. Cancer of the breast, endometrium, and ovary: Geographical correlation. Eur J Cancer Clin Oncol 1989;25:1917-25.
19. 19. Cooper C, Champion G, Melton LJ. Hip fracture in the elderly: A world wide projection. Osteoporos Int 1992;2:825-9.
20. 20. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series no. 843. Geneva, Switzerland: World Health Organization, 1994:11-3.
21. 21. Eden JA, Bush T, Nand S, Wren BG. A case control study of combined continuous estrogen-progestin replacement therapy among women with personal history of breast cancer. Menopause 1995;2:67-72.
22. 22. Roussouw JE, Harlan WR. Postmenopausal estrogen and the risk of breast cancer: The need for randomised trials. Ann Epidemiol 1994;4:255-6.